When was Nuvaira founded?

Nuvaira was founded in 2008 and raised its 1st funding round 1 year after it was founded.

Where is Nuvaira located?

Nuvaira is headquartered in Minneapolis, United States.

How many employees does Nuvaira have?

As of May 31, 2026, the latest employee count at Nuvaira is 16.

Is Nuvaira a funded company?

Nuvaira is a funded company, having raised a total of $227M across 10 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Apr 14, 2009.

When was the latest funding round of Nuvaira?

Nuvaira's latest funding was a $***** Series E round on Feb 20, 2026, with participation from 0 investor.

Where does Nuvaira rank among its competitors?

Nuvaira ranks 1st amongst 3 active competitors, only 1 of which is funded. Nuvaira, which secured $35.8M in Feb, 2026.

Nuvaira - 2026 Company Profile, Team, Funding & Competitors

Nuvaira is a series E company based in Minneapolis (United States), founded in 2008 by Martin Mayse. It operates as a Provider of a catheter-based system for patients suffering from COPD. Nuvaira has raised $227M in funding from investors like USVP, Advanced Technology Ventures and Endeavour Vision. The company has 3 active competitors, including 1 funded and 1 that has exited. Its top competitors are Asthmatx and D R Burton.

Company Details

Provider of a catheter-based system for patients suffering from COPD. The company is developing Nuvaira Lung Denervation System, a catheter-based system used to treat the overactive airway nerves in a procedure called Targeted Lung Denervation (TLD). It provides an ablative therapy that opens obstructed airways to improve breathing.

Website: nuvaira.com
Social
Email ID: *****@nuvaira.com
Phone Number: +1 **********

Key Metrics

Founded Year

2008

Location

Minneapolis, United States

Stage

Series E

Total Funding

$227M in 10 rounds

Latest Funding Round

Series E, Feb 20, 2026, $*****

Investors

USVP & 13 more

Ranked

1^st among 3 active competitors

Employee Count

16 as on May 31, 2026

Similar Companies

Asthmatx & 1 more

View Nuvaira's full profile

Nuvaira is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Nuvaira, Inc. CIN: 263112330 , United States, Active	Dec 31, 1999	-	18 (As on Dec 31, 2024)	-

Nuvaira has raised a total funding of $227M over 10 rounds. Its first funding round was on Apr 14, 2009. Nuvaira has 14 institutional investors.

Here is the list of recent funding rounds of Nuvaira:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 20, 2026	4909875	Series E	4412326	9635404	1814869	5130708
Nov 28, 2023	1879067	Series E	9712031	1442188	9847789	4944414
Jan 19, 2022	7009528	Series E	2531307	2769358	5182702	6417014

Access funding benchmarks and valuations. Sign up today!

View details of Nuvaira's funding rounds and investors

The founders of Nuvaira is Martin Mayse. Dennis Wahr is the CEO of Nuvaira.

Here are the details of Nuvaira's key team members:

Martin Mayse: Former Co-Founder of Nuvaira and founder of 1 other company.
Contact Info: 1 email address
Dennis Wahr: CEO of Nuvaira.

View details of Nuvaira's Founder profiles and Board Members

Nuvaira's employee count trend

Nuvaira has 16 employees as of May 26. Here is Nuvaira's employee count trend over the years:

Uncover Nuvaira's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Nuvaira include Asthmatx and D R Burton. Here is the list of Top 10 competitors of Nuvaira, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nuvaira 2008, Minneapolis (United States), Series E	Provider of a catheter-based system for patients suffering from COPD	$227M	Versant Ventures, Vertex Holdings & 12 others	61/100
2nd	Asthmatx 2003, Sunnyvale (United States), Acquired	SEO, web hosting, lighting, and hardware solutions for home and business	$50M	Saints Capital, HBM Partners & 8 others	39/100
3rd	D R Burton 2015, Raleigh (United States), Unfunded	Provider of products for generating positive pressure for lung disease patients	-	-	29/100